@article{TCR8766,
author = {Glen R. B. Irving and Dileep N. Lobo},
title = {Pancreatic ductal adenocarcinoma—a new hope?},
journal = {Translational Cancer Research},
volume = {5},
number = {Suppl 2},
year = {2016},
keywords = {},
abstract = {Pancreatic ductal adenocarcinoma (PDAC) is typically an advanced and aggressive disease and improving outcomes for patients with this cancer remains a significant challenge. Few patients present with resectable disease, and recurrence rates after surgery remain high (70–80%). Modern chemotherapy (CMT) and radiotherapy (RT) regimens have made small improvements to survival and many of these treatments confer little benefit whilst delivering unpleasant side-effects. Alternative treatment modalities, such as electroporation, are under development and pancreatic cancer still awaits a “game-changer”.},
issn = {2219-6803}, url = {https://tcr.amegroups.org/article/view/8766}
}